BACKGROUND: Hepatic pedicle clamping is often used during liver resection. While its use reduces blood loss and transfusion requirements, the long-term effect on survival and recurrence has been debated. This study evaluates the effect of hepatic pedicle clamping [i.e., Pringle maneuver (PM)] on survival and recurrence following hepatic resection for colorectal liver metastasis (CRLM). METHODS: Patients who underwent R0 resection for CRLM from 1991 to 2004 were identified from a prospectively maintained database. Operative, perioperative, and clinicopathological variables were analyzed. The primary outcomes were disease-free survival (DFS) and liver recurrence (LR). Disease extent was categorized using a well-defined clinical risk score (CRS). Subgroup analysis was performed for patients given preoperative systemic chemotherapy and postoperative pump chemotherapy. RESULTS: This study included 928 consecutive patients with median follow-up of 8.9 years. PM was utilized in 874 (94%) patients, with median time of 35 min (range 1-181 min). On univariate analysis, only resection type (p<0.001) and tumor number (p=0.002) were associated with use of PM. Younger age (p=0.006), longer operative time (p<0.001), and multiple tumors (p=0.006) were associated with prolonged PM (>60 min). There was no association between DFS, overall survival (OS) or LR and Pringle time. Neither the CRS nor use of neoadjuvant therapy stratified disease-related outcome with respect to use of PM. CONCLUSIONS: PM was used in most patients undergoing resection for CRLM and did not adversely influence intrahepatic recurrence, DFS, or OS.
BACKGROUND: Hepatic pedicle clamping is often used during liver resection. While its use reduces blood loss and transfusion requirements, the long-term effect on survival and recurrence has been debated. This study evaluates the effect of hepatic pedicle clamping [i.e., Pringle maneuver (PM)] on survival and recurrence following hepatic resection for colorectal liver metastasis (CRLM). METHODS:Patients who underwent R0 resection for CRLM from 1991 to 2004 were identified from a prospectively maintained database. Operative, perioperative, and clinicopathological variables were analyzed. The primary outcomes were disease-free survival (DFS) and liver recurrence (LR). Disease extent was categorized using a well-defined clinical risk score (CRS). Subgroup analysis was performed for patients given preoperative systemic chemotherapy and postoperative pump chemotherapy. RESULTS: This study included 928 consecutive patients with median follow-up of 8.9 years. PM was utilized in 874 (94%) patients, with median time of 35 min (range 1-181 min). On univariate analysis, only resection type (p<0.001) and tumor number (p=0.002) were associated with use of PM. Younger age (p=0.006), longer operative time (p<0.001), and multiple tumors (p=0.006) were associated with prolonged PM (>60 min). There was no association between DFS, overall survival (OS) or LR and Pringle time. Neither the CRS nor use of neoadjuvant therapy stratified disease-related outcome with respect to use of PM. CONCLUSIONS: PM was used in most patients undergoing resection for CRLM and did not adversely influence intrahepatic recurrence, DFS, or OS.
Authors: Melanie E Tsang; Paul J Karanicolas; Rogeh Habashi; Eva Cheng; Sherif S Hanna; Natalie G Coburn; Calvin H L Law; Julie Hallet Journal: HPB (Oxford) Date: 2015-09 Impact factor: 3.647
Authors: Kit Fai Lee; Charing C N Chong; Sunny Y S Cheung; John Wong; Andrew K Y Fung; Hon Ting Lok; Paul B S Lai Journal: World J Surg Date: 2019-12 Impact factor: 3.352
Authors: Wouter G van Riel; Rowan F van Golen; Megan J Reiniers; Michal Heger; Thomas M van Gulik Journal: Hepatobiliary Surg Nutr Date: 2016-02 Impact factor: 7.293
Authors: Raphael L C Araujo; Danielle Cesconetto; Vagner Birk Jeismann; Gilton Marques Fonseca; Fabricio Ferreira Coelho; Jaime Arthur Pirola Kruger; Paulo Herman Journal: Arq Bras Cir Dig Date: 2016 Nov-Dec
Authors: Suguru Yamashita; Aradhana M Venkatesan; Takashi Mizuno; Thomas A Aloia; Yun S Chun; Jeffrey E Lee; Jean-Nicolas Vauthey; Claudius Conrad Journal: JAMA Surg Date: 2017-10-18 Impact factor: 14.766